McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions
McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions of Santa Ana, CA is a registered 503B outsourcing facility. When the FDA last inspected it, what it found, and what that means for a compounded prescription.
McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions of Santa Ana, California is registered with the FDA as a 503B outsourcing facility. A 503B may compound medication in bulk without a prescription for a named patient, and it is inspected against manufacturing standards — which a 503A compounding pharmacy is not.
Its FDA record
| Check | What the register shows | Source |
|---|---|---|
| Registered since | Jan 11, 2023 | FDA register |
| Registration renewed | Dec 2, 2025 | FDA register |
| Last FDA inspection | Not yet inspected | FDA register |
| Form 483 issued | Not applicable — never inspected | FDA register |
| Recall conducted | Not applicable — never inspected | FDA register |
| Action from last inspection | None on record | FDA register |
| Compounds sterile drugs from bulk | Yes | Facility registration |
Comparing programmes instead?
This page is the FDA’s record of one compounder. No programme we review names it as its pharmacy. If you came here to vet a telehealth programme, start with the ones we rate highest.
- FDA warning lettersPublished compliance actions, updated weekly
- FDA registered outsourcing facilities503B register, with inspection and enforcement status
- FDA National Drug Code directoryLabeler, product and package listings
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.